(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with Dermatitis, Contact, Phototoxic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baptista-Hon, D; Bull, F; Dalgaty, F; Gallacher, M; Hales, TG; Ibbotson, SH; Wright, L | 1 |
1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and Dermatitis, Contact, Phototoxic
Article | Year |
---|---|
Menthol reduces phototoxicity pain in a mouse model of photodynamic therapy.
Topics: Acrylamides; Animals; Animals, Newborn; Antipruritics; Bridged Bicyclo Compounds, Heterocyclic; Dermatitis, Phototoxic; Disease Models, Animal; Evoked Potentials; HEK293 Cells; Humans; Hyperalgesia; Lidocaine; Lipid Metabolism; Menthol; Mice; Mice, Inbred C57BL; Neurons; Pain; Pain Threshold; Photochemotherapy; Reactive Oxygen Species; TRPV Cation Channels | 2018 |